HomeCompareNVIVQ vs ADC

NVIVQ vs ADC: Dividend Comparison 2026

NVIVQ yields 540.54% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVIVQ wins by $112786.05M in total portfolio value
10 years
NVIVQ
NVIVQ
● Live price
540.54%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112786.22M
Annual income
$82,692,515,806.61
Full NVIVQ calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — NVIVQ vs ADC

📍 NVIVQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVIVQADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVIVQ + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NVIVQ pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVIVQ
Annual income on $10K today (after 15% tax)
$45,945.95/yr
After 10yr DRIP, annual income (after tax)
$70,288,638,435.62/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, NVIVQ beats the other by $70,288,570,735.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVIVQ + ADC for your $10,000?

NVIVQ: 50%ADC: 50%
100% ADC50/50100% NVIVQ
Portfolio after 10yr
$56393.20M
Annual income
$41,346,297,726.93/yr
Blended yield
73.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

NVIVQ
No analyst data
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVIVQ buys
0
ADC buys
0
No recent congressional trades found for NVIVQ or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVIVQADC
Forward yield540.54%4.11%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$112786.22M$176.9K
Annual income after 10y$82,692,515,806.61$79,647.25
Total dividends collected$110217.05M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: NVIVQ vs ADC ($10,000, DRIP)

YearNVIVQ PortfolioNVIVQ Income/yrADC PortfolioADC Income/yrGap
1← crossover$64,754$54,054.05$10,987$577.21+$53.8KNVIVQ
2$396,410$327,123.28$12,293$855.34+$384.1KNVIVQ
3$2,295,726$1,871,567.31$14,088$1,290.70+$2.28MNVIVQ
4$12,586,137$10,129,710.14$16,660$1,994.91+$12.57MNVIVQ
5$65,369,349$51,902,182.37$20,525$3,181.85+$65.35MNVIVQ
6$321,877,325$251,932,121.38$26,654$5,286.90+$321.85MNVIVQ
7$1,503,762,535$1,159,353,797.14$37,006$9,259.47+$1503.73MNVIVQ
8$6,671,013,644$5,061,987,731.83$55,862$17,338.74+$6670.96MNVIVQ
9$28,124,961,234$20,986,976,635.20$93,452$35,300.32+$28124.87MNVIVQ
10$112,786,224,327$82,692,515,806.61$176,931$79,647.25+$112786.05MNVIVQ

NVIVQ vs ADC: Complete Analysis 2026

NVIVQStock

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Full NVIVQ Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this NVIVQ vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVIVQ vs SCHDNVIVQ vs JEPINVIVQ vs ONVIVQ vs KONVIVQ vs MAINNVIVQ vs NNNNVIVQ vs EPRTNVIVQ vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.